Loading stock data…
Certara (CERT)
$7.74-0.20 (-2.58%)
Market OpenUpdated 3:43 PM EDT
Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the Americas, Europe, the Middle East, Africa, and Asia Pacific.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Certara, Inc. in the Healthcare sector is trading at $7.74 with a market capitalization of $930M. Wall Street consensus targets $8.34 (10 analysts), implying a +7.8% move over the next 12 months. The stock is currently 44% below its 52-week high of $13.88, remaining 7.1% above its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality, Altman Z in the distress zone. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +7.8% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $106.92M↑ | $103.65M↓ | $104.62M | $104.57M↓ | $106.00M |
| Gross Profit | $65.30M↑ | $64.48M↓ | $64.90M↑ | $63.85M↓ | $64.48M |
| Operating Income | -$4.30M↓ | $836,000↓ | $3.00M↓ | $9.55M↑ | $7.62M |
| Net Income | -$8.76M↓ | -$5.89M↓ | $1.52M↑ | -$1.97M↓ | $4.74M |
Peer Comparison
JNJUNHPFE
Fundamentals
Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the Americas, Europe, the Mi...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$930.26M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-1.48%
Volume
Today's trading volume
1.00M
Recent News
The Bull Case For Certara (CERT) Could Change Following Wider Q2 Loss And Leadership Shake-Up - Learn Why
In early August 2026, Certara reported second-quarter results showing slightly higher sales of US$93.27 million but a much larger net loss of US$55.27 million, alongside executive reshuffling including the departure of President and Chief Commercial Officer Leif Pedersen and the appointment of Julien Perrier as Chief Commercial Officer and Eric Jahn as Chief Information Officer. At the same time, Certara reaffirmed its 2026 revenue outlook while expanding its share repurchase authorization...
Certara (CERT) Q2 2026 Earnings Call Transcript
Software revenue hit 53% of total as AI-assisted code boosted development 65% year over year.
Certara, Inc. Q2 2026 Earnings Call Summary
Moby summary of Certara, Inc.'s Q2 2026 earnings call
Certara Q2 Earnings Call Highlights
Certara (NASDAQ:CERT) reported second-quarter 2026 revenue of $93.3 million, up 1% year over year, as software growth offset a decline in services revenue. Management reaffirmed its full-year revenue outlook while outlining further changes to its commercial organization, cost structure and artificia
Certara, Inc. (CERT) Q2 Earnings and Revenues Lag Estimates
Certara (CERT) delivered earnings and revenue surprises of -20.00% and -5.71%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?